ONCOLOGY: February 2009 Volume 23 Number 2 Supplement 1

Article

Infusion Reactions Associated With Monoclonal Antibodies in Patients With Solid Tumors This supplement and associated publication costs were funded by Amgen

Infusion Reactions Associated With Monoclonal Antibodies in Patients With Solid Tumors
This supplement and associated publication costs were funded by Amgen


Infusion reactions are well-known in cancer treatment, occurring with both cytotoxic and biologic agents. The five articles presented in this supplement to ONCOLOGY cover a wide range of topics related to antibody-induced infusion reactions: immunologic mechanisms and risk factors; a focus on anaphylaxis; US and EU perspectives on the state of clinical trials; a health economic analysis of the burden on patients, caregivers, and providers; and a nursing perspective on infusion reaction management.
 

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content